- The Company is developing an enhanced immunosuppressive regimen in consultation with a panel of multi-disciplinary clinical experts and engaging…
SAN FRANCISCO, CALIFORNIA, June 13, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology…
TAINAN, June 13, 2025 /PRNewswire/ -- Merry Life Biomedical Company announces the launch of its global Phase II clinical trial…
1st production of pharmaceutical grade egg and milk challenge mealsProduct portfolio of challenge meals now includes peanut, milk and eggInnovation…
ST. LOUIS--(BUSINESS WIRE)--EyeCare Partners (ECP), the nation’s leading provider of clinically integrated eye care, released its first Quality and Outcomes…
Automated screening cuts patient assessment time by 30 minutes in real-world useBOSTON--(BUSINESS WIRE)--Wysa, the global leader in AI-guided mental health…
Real-time, recursive, fact-first architecture reduces AI-generated "note bloat" by 65 percent and minimizes post-visit edits - transforming passive documentation into…
JUPITER, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- In a milestone rarely achieved in the clinical laboratory industry, Access Medical…
Presentation to highlight updated six-month clinical results of a hypoimmune-modified primary pancreatic islet cell therapy for patients with type 1…
— Milestone Achieved Through Growing Clinical Evidence Demonstrating Real-World Impact on Infection Management — — MeMed and Physicians Premier Celebrated…